Yu Zhijun, Cheng Kaihui, Xin Yue, Sun Weiyang, Li Xue, Huang Jing, Zhang Kun, Yang Songtao, Wang Tiecheng, Zheng Xuexing, Wang Hualei, Hua Yuping, Chai Hongliang, Qin Chuan, Qian Jun, Gao Yuwei, Xia Xianzhu
Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, People's Republic of China; Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Military Veterinary Research Institute of Academy of Military Medical Sciences, Changchun 130122, People's Republic of China.
Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Military Veterinary Research Institute of Academy of Military Medical Sciences, Changchun 130122, People's Republic of China; Dairy Cattle Research Center, Shandong Academy of Agricultural Sciences, Jinan 250132, People's Republic of China.
Vet Microbiol. 2014 Dec 5;174(3-4):316-321. doi: 10.1016/j.vetmic.2014.09.032. Epub 2014 Oct 14.
H6N1 avian influenza viruses (AIVs) are one of the most abundantly detected avian influenza virus subtype, and a human H6N1 infection case has been reported in 2013. H6N1 AIVs may pose a potential human risk, however, the factors that promote the replication of H6N1 viruses in mammals remain poorly understood. Here, we generated mouse-adapted variants of a H6N1 virus (A/Mallard/SanJiang/275/2007) to identify adaptive changes that confer enhanced virulence to H6N1 viruses in mammals. After eight sequential passages in mice, the mouse lethal doses (MLD50) of the variants were reduced >1000-fold compared to the parental virus. We found that the variants displayed the greatest enhancement of replication in vitro and in vivo, and also were capable of replicating in the brains of infected mice. These observations suggest that enhanced growth characteristics and modified cell tropism may contribute to increased virulence of H6N1 AIVs in mice. Sequencing of the variants revealed amino acid changes in the PB2 (E627K), PA (T97I), and HA (N394T) proteins. Our results suggest that these mutations involved in the enhancement of the ability of H6N1 virus to efficient replicate and cause severe disease in mammals.
H6N1禽流感病毒(AIVs)是检测到的最为常见的禽流感病毒亚型之一,2013年曾报告过1例人类感染H6N1的病例。H6N1 AIVs可能对人类构成潜在风险,然而,促进H6N1病毒在哺乳动物中复制的因素仍知之甚少。在此,我们培育出一种H6N1病毒(A/绿头鸭/三江/275/2007)的小鼠适应变体,以确定能使H6N1病毒在哺乳动物中增强毒力的适应性变化。在小鼠中连续传代8次后,这些变体菌株的小鼠致死剂量(MLD50)与亲代病毒相比降低了1000倍以上。我们发现,这些变体菌株在体外和体内均表现出最强的复制增强能力,并且能够在受感染小鼠的大脑中复制。这些观察结果表明,生长特性的增强和细胞嗜性的改变可能有助于H6N1 AIVs在小鼠中毒力的增加。对这些变体菌株进行测序,发现PB2(E627K)、PA(T97I)和HA(N394T)蛋白中存在氨基酸变化。我们的结果表明,这些突变与H6N1病毒在哺乳动物中高效复制和引发严重疾病的能力增强有关。